Who
Elizabeth Czerepak
Director
Company insider
Files Form 4 as: Director, Delcath Systems; Officer, Scilex Holding; EVP & Chief Financial Officer, Sorrento Therapeutics; Director, Spectrum Pharmaceuticals; CFO and EVP Corp. Development, Altimmune; Director and 10% owner, Affymax.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 3
- First trade
- 14 Dec 2006
- Last trade
- 13 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 May 2026filed 14 May 2026 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 12 Jun 2023filed 21 Jun 2023 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —19,682 at $0.00 | filing |
| 17 Jan 2023filed 17 Jan 2023 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 18 May 2022filed 20 May 2022 | Sorrento Therapeuticsoption or derivative | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 4 May 2022filed 6 May 2022 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 18 Nov 2021filed 18 Nov 2021 | Sorrento Therapeuticsoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 5 Aug 2021filed 9 Aug 2021 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 23 Nov 2020filed 25 Nov 2020 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 18 Jun 2020filed 19 Jun 2020 | Spectrum Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 18 Jun 2020filed 19 Jun 2020 | Spectrum Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 20 Jun 2019filed 2 Jul 2019 | Spectrum Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 20 Jun 2019filed 2 Jul 2019 | Spectrum Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 22 Sep 2017filed 26 Sep 2017 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 22 Sep 2017filed 26 Sep 2017 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 4 May 2017filed 8 May 2017 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —178,595 | filing |
| 4 May 2017filed 8 May 2017 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,727 | filing |
| 9 Oct 2007filed 11 Oct 2007 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.